Experimental study demonstrates that KLK5 cleaves profilaggrin in human keratinocytes, indicating a critical role in epidermal barrier formation.
Filaggrin protein is synthesized in the stratum granulosum of the skin and contributes to the formation of the human skin barrier. Profilaggrin is cleaved by proteolytic enzymes and converted to functional filaggrin, but its processing mechanism remains not fully elucidated. Kallikrein-related peptidase 5 (KLK5) is a major serine protease found in the skin, which is secreted from lamellar granules following its expression in the stratum granulosum and activated in the extracellular space of the stratum corneum. Here, we searched for profilaggrin-processing protease(s) by partial purification of epidermal extracts and found KLK5 as a possible candidate. We used high performance liquid chromatography coupled with electrospray tandem mass spectrometry to show that KLK5 cleaves profilaggrin. Furthermore, based on a proximity ligation assay, immunohistochemistry, and immunoelectron microscopy analysis, we reveal that KLK5 and profilaggrin co-localize in the stratum granulosum in human epidermis. KLK5 knockdown in normal cultured human epidermal keratinocytes resulted in higher levels of profilaggrin, indicating that KLK5 potentially functions in profilaggrin cleavage. Background: Filaggrin is a skin barrier function-related factor processed from profilaggrin. The identity of human profilaggrin-processing enzymes remains unclear. Results: The protease kallikrein 5 (KLK5) specifically processed a recombinant human filaggrin fragment fused to a linker. Conclusion: KLK5 is potentially a key molecule in human profilaggrin maturation. Significance: KLK5 may function in formation of the skin barrier.
No takes yet. Share an insight, caveat, or question.
Sakabe et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: